Barkley and three other ADHD experts who reviewed Akili’s research said the firm was overpromising by implying that EndeavorRx can provide meaningful help for children struggling in school and at home with the sometimes-debilitating neurodevelopmental disorder, whose symptoms include distraction, forgetfulness and impulsivity.